Quick Links : Search PubMed , Finding Full Text , PubMed Advanced Search , Clinical Queries , Single Citation Matcher , FAQs & User Guide , Explore MeSH Database , Explore PubMed Journals
dbGap News
News and announcements from the database of Genotypes and Phenotypes (dbGaP)
- New | phs004714.v1.p1 | Cardiothoracic Surgical Trials Network and Cardiovascular Cell Therapy Research Network - Left Ventricular Assist Device Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function (CTSN-CCTRN-LVAD-BioLINCC) July 9, 2026Cardiothoracic Surgical Trials Network and Cardiovascular Cell Therapy Research Network - Left Ventricular Assist Device Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function (CTSN-CCTRN-LVAD-BioLINCC) (study page | release notes)
- New | phs003099.v2.p1 | Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick) July 9, 2026Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick) (study page | release notes)
- New | phs004720.v1.p1 | Blood and Marrow Clinical Trials Network: A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease (BMT-CTN-1503-BioLINCC) July 9, 2026Blood and Marrow Clinical Trials Network: A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease (BMT-CTN-1503-BioLINCC) (study page | release notes)
- New | phs003628.v1.p1 | Subtyping of Small Cell Lung Cancer Using ChIP-Seq of Plasma Cell-Free Nucleosomes and Matched Tumor Transcriptomes July 9, 2026Subtyping of Small Cell Lung Cancer Using ChIP-Seq of Plasma Cell-Free Nucleosomes and Matched Tumor Transcriptomes (study page | release notes)
- New | phs004712.v1.p1 | Cardiovascular Cell Therapy Research Network - A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy (CCTRN-SENECA-BioLINCC) July 9, 2026Cardiovascular Cell Therapy Research Network - A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy (CCTRN-SENECA-BioLINCC) (study page | release notes)
- New | phs004718.v1.p1 | Blood and Marrow Transplant Clinical Trials Network - A Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN-1401-BioLINCC) July 9, 2026Blood and Marrow Transplant Clinical Trials Network - A Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN-1401-BioLINCC) (study page | release notes)
- New | phs000435.v4.p1 | Whole Exome Sequencing of Chronic Lymphocytic Leukemia July 9, 2026Whole Exome Sequencing of Chronic Lymphocytic Leukemia (study page | release notes)
- New | phs004698.v1.p1 | Blood and Marrow Clinical Trials Network - A Multi-Center, Phase III, Randomized Trial of RIC, and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients with Hematologic Malignancies (BMT CTN-1101-BioLINCC) July 8, 2026Blood and Marrow Clinical Trials Network - A Multi-Center, Phase III, Randomized Trial of RIC, and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients with Hematologic Malignancies (BMT CTN-1101-BioLINCC) (study page | release notes)
- New | phs004705.v1.p1 | Blood and Marrow Clinical Trials Network - Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (BMT CTN-1302-BioLINCC) July 8, 2026Blood and Marrow Clinical Trials Network - Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (BMT CTN-1302-BioLINCC) (study page | release notes)
- New | phs004709.v1.p1 | Blood and Marrow Clinical Trials Network - A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN-1203-BioLINCC) July 8, 2026Blood and Marrow Clinical Trials Network - A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN-1203-BioLINCC) (study page | release notes)